Acacia Research Corporation — Q1 2014 Form 10-Q
Reporting period: Three months ended March 31, 2014; comparisons are with Q1 2013 unless otherwise noted. Acacia’s subsidiaries acquire or control patent rights and generate revenue through licensing and enforcement. The interim financial statements are unaudited.
Financial results
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Revenue | $12.6 million | $76.9 million |
| Operating costs and expenses | $38.6 million | $69.8 million |
| Operating income (loss) | $(26.1) million | $7.1 million |
| Net income (loss) attributable to Acacia | $(24.4) million | $5.1 million |
| Basic and diluted loss per share | $(0.51) | — |
| Operating cash flow | $(20.4) million | $16.8 million |
Revenue fell 84%, primarily because both the number of agreements and average revenue per agreement declined: 20 agreements at an average $629,000 in Q1 2014 versus 29 at $2.65 million in Q1 2013. Operating expenses decreased 45%, but not enough to offset the revenue decline. Patent amortization rose to $14.5 million, including a $2.6 million partial portfolio write-down reflecting lower expected future cash flows. The filing does not provide a conventional gross-margin measure.
Cash receipts from licensees were $5.4 million, down from $41.4 million; operating cash outflows were $25.8 million. Investing activities provided $33.3 million, largely from investment maturities and sales, while financing activities used $6.2 million, mainly for dividends. Cash and cash equivalents increased by $6.7 million during the quarter.
Financial position and liquidity
- At March 31, 2014, cash and cash equivalents were $133.4 million and short-term investments were $95.6 million, totaling $229.0 million, versus $256.7 million at year-end 2013.
- Current assets were $253.3 million; current liabilities were $35.4 million. Working capital was $217.8 million, down from $247.7 million at December 31, 2013.
- Total liabilities were $39.5 million. The company reported no long-term debt or committed credit lines.
- Accounts receivable rose to $13.5 million from $6.3 million; royalties and contingent legal fees payable fell to $3.9 million from $10.4 million. Management said most receivables were collected or scheduled for collection in Q2 2014.
- Patent acquisition-related contractual payments totaled $19.3 million, all due within one year; operating lease obligations totaled $4.7 million.
Material developments, outlook and risks
- Acacia invested in three new patent portfolios during the quarter, recording $16.2 million in upfront advances or payments, including $15.3 million accrued for future payment. It reported 20 new revenue agreements across 21 licensing programs, with three programs generating initial revenue.
- Management said cash, investments, anticipated operating cash flows and other available external credit sources should meet cash requirements through at least May 2015. No specific revenue or earnings guidance was provided; management cautioned that quarterly licensing revenue is uneven and not necessarily indicative of full-year results.
- The company is shifting toward fewer, higher-quality patent portfolios and expanding international activity. Management expects patent-related legal expenses to fluctuate and potentially increase with trials, international enforcement and portfolio prosecution.
- Revenue concentration is significant: one licensee contributed 39% of Q1 2014 revenue. Two licensees represented approximately 71% of quarter-end receivables. Patent licensing outcomes, litigation timing, legal costs, regulatory changes and the ability to secure future licenses are key risks.
- A California insurance-fraud-related case was set for trial on June 9, 2014, after the court denied Acacia’s summary-judgment motion on April 30. Acacia stated it believed the claims lacked merit and did not expect a material adverse effect, while noting no assurance of success. Patent enforcement litigation also carries potential exposure to sanctions or fee awards.
- The company recorded a $1.4 million income tax benefit, but increased valuation allowances for most net operating loss carryforwards and certain other tax assets generated in the quarter because of uncertainty about realization.
- Acacia paid a quarterly dividend of $0.125 per share ($6.3 million total) and announced the next $0.125 dividend for payment on May 30, 2014. Its $70 million repurchase authorization was scheduled to expire May 14, 2014; $62.1 million remained available at the reported date.
Important facts for investors to verify
- Whether licensing revenue and cash collections recover after the sharp year-over-year decline, given the company’s dependence on large, episodic agreements.
- Progress and expected economics of the new patent portfolios, including the $19.3 million of scheduled acquisition payments and the portfolio write-down.
- Resolution and potential costs of the Strathmann litigation and other patent enforcement actions, including any effects of evolving patent laws or court rules.
- Whether operating cash burn, customer concentration and the reduced cash-and-investment balance affect management’s liquidity outlook.
- Continuation of dividends and any stock repurchases after the stated authorization expiry; future dividends remain subject to board discretion.